Your Source for Venture Capital and Private Equity Financings

Hexagon Bio Lands $77.3 Million Series B

2023-02-13
MENLO PARK, CA, Hexagon Bio, a biopharmaceutical company, has raised a $77.3 million Series B financing.
Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, announced that it has raised a $77.3 million Series B financing and made key appointments to its leadership team. Existing investors, including The Column Group, Two Sigma Ventures, 8VC, and Nextech, participated in the Series B round, joined by additional new investors, including Canada Pension Plan Investment Board (CPP Investments).
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors